Frontlight ResearchEarly access
Active, not recruitingNo phase
SEDVasc (RaDiCo Cohort) (RaDiCo-SEDVasc)
Key facts
- Who runs it
- Institut National de la Santé Et de la Recherche Médicale, France
- Where
- France17 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 340 people enrolled
- Started
- 5 Dec 2016
- Expected to end
- Jan 2028
- Type of study
- Observational
- Record updated
- 12 February 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patients eligible for inclusion in this study have to fulfil all of the following criteria:
- Patients (adults and children) with genetically-proven vEDS (presence of a pathogenic mutation at the COL3A1 gene)
- Patients (or his/her legal guardian) who does not oppose to his/her personal data collection; There are no exclusion criteria for this study
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to describe the natural course of vascular Ehlers-Danlos syndrome, in particular the order of appearance of different types of complications (arterial, digestive, pulmonary and uterine).
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- National Cohort on the Vascular Ehlers-Danlos Syndrome (SEDv)
- Record updated
- 12 February 2026